![Quinton Oswald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Quinton Oswald
Direktor/Vorstandsmitglied bei
Notal Vision Ltd.
Vermögen: - $ am 30.06.2026
Profil
Quinton C.
Oswald currently works at Notal Vision Ltd., as Director from 2019.
Mr. Oswald also formerly worked at SARcode Bioscience, Inc., as Chief Executive Officer from 2010 to 2013, Neurotech Pharmaceuticals, Inc. (United States), as President & Chief Executive Officer, Opthea Ltd., as Independent Non-Executive Director from 2022 to 2025, Genentech, Inc., as Vice President & Head-Business Unit, QLT, Inc., as Principal, Novartis Corp., as Principal, and Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd., as Principal.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.09.2025 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Quinton Oswald
| Unternehmen | Position | Beginn |
|---|---|---|
Notal Vision Ltd.
 Notal Vision Ltd. Medical/Nursing ServicesHealth Services Provides diagnostic and remote monitoring services for AMD patients | Direktor/Vorstandsmitglied | 04.05.2016 |
Ehemalige bekannte Positionen von Quinton Oswald
| Unternehmen | Position | Ende |
|---|---|---|
| CERYVYN THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 02.06.2025 |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Vorstandsvorsitzender | 01.04.2013 |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Vorstandsvorsitzender | - |
Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | - |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
SARcode Bioscience, Inc.
SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
Notal Vision Ltd.
Notal Vision Ltd. Medical/Nursing ServicesHealth Services Provides diagnostic and remote monitoring services for AMD patients | Health Services |
Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. |
Wählen Sie MarketScreener 
